Cure HHT Leads Global Breakthrough in Bleeding Standards, Paving the Way for Future HHT Therapies
A newly published international consensus report—developed under the leadership of Cure HHT, the only nonprofit...
A Major Step Forward for HHT Treatment: Promising Preclinical Data from Diagonal Therapeutics
We’re excited to share two important updates from our partners at Diagonal Therapeutics. At this...
Volunteers Needed! Join Cure HHT on Capitol Hill
We are calling upon volunteers to Join us in Washington, DC, for HHT Hill Day...
HHT Global Awareness Day
Global HHT Awareness Day is just a few days away. Did you know, this date...
June Awareness – Be an HHT Changemaker!
June marks one of the most important months in the calendar year for those who...
A Monumental $128 Million Step Forward for HHT Research
Today is a monumental day for HHT. The new biotechnology company, Diagonal Therapeutics, officially launched...
HHT Continuing Education Program for medical professionals
We are excited to announce the launch of the HHT Continuing Education Hub, an online platform...
Cure HHT Takes on Capitol Hill
This month, our group of Cure HHT staff, patient advocates, physicians and researchers descended upon...
15th HHT International Scientific Conference
The 15th HHT International Scientific Conference will take place in Mandelieu-la-Napoule, France from October 15-19, 2024....
Leaving a Lasting Legacy Through Planned Giving
One of the most powerful ways to contribute to Cure HHT's mission is through planned...
Send hearts & kisses this special Rare Disease Month!
February is Rare Disease Month and we want to show our stripes and appreciation on this...
Dr. Anthony Anzell Presented with $20,000 Research Grant
The University of Pittsburgh’s Dr. Anthony Anzell Presented with $20,000 Research Grant from Uplifting Athletes...
Cure HHT Canada now registered as a charitable organization in Canada
We are excited to announce the establishment of Cure HHT Canada as a registered, tax-deductible charitable organization in...
